Ressources

Guidance and Jurisdictional Evidence Regarding The Use of Vaccine Passports

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 21, 2021

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: juin 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: juin 15, 2021

COVID-19 : Nettoyage et désinfection de surfaces

Product: — Institut national de santé publique du Québec

About Coronavirus Aerosols Hospital Infection Control Infection Control Guidelines Sterilization

www.inspq.qc.ca Dernière mise à jour: juin 14, 2021

Also available in English

SRAS-CoV-2 : Mesures de prévention et contrôle des infections pour les unités d’hémodialyse

Product: — Institut national de santé publique du Québec

Hospital Infection Control Infection Control Guidelines

www.inspq.qc.ca Dernière mise à jour: juin 2, 2021

Also available in English

Design Strategies To Prevent Respiratory Infection In Congregate Care Settings

Product: — Evidence Synthesis Network

Hospital Infection Control Infection Control Guidelines

esnetwork.ca Dernière mise à jour: juin 1, 2021

Plasma de convalescents ou immunoglobuline hyperimmune chez les personnes atteintes de la COVID‐19: une revue systématique dynamique

Product: — Cochrane Library

Drug Interventions Immune System Treatments Vaccines & Immunity

www.cochranelibrary.com Dernière mise à jour: mai 20, 2021

Also available in English

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Dernière mise à jour: mai 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 11, 2021

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID‑19 Vaccination: Interim Guidance for Healthcare Professionals in Emergency Department and Inpatient Settings

Product: — Science Table

Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 10, 2021